drugset / Trial / NCT04218513
Drug-drug Interaction Study Between Edaravone and 2-Aminoethanesulfonic Acid in Compound Edaravone Injection
RandomizedCrossoverOpen-labelBasic science
Summary
An experiment to evaluate the drug-drug interaction of formula edaravone and formula 2-aminoethanesulfonic acid in compound edaravone injection.
Timeline
- Start
- 2019-05-10
- Primary completion
- 2019-05-31
- Completion
- 2019-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 2-Aminoethanesulfonic Acid | Unknown | 600 mg | Intravenous |
| Subject | Edaravone | Unknown | 30 mg | Intravenous |
Indications
No indication recorded.